Cantimer was founded in 2006, by two experienced entrepreneurs, following successful licensing of technology originally developed at Northern Arizona University. The Company is based in Menlo Park, California, and has been funded to date through a combination of U.S. Government Small Business Innovation Research (SBIR) grants and seed capital from individual investors.
Cantimer has had five patents issued and has an additional four patents pending.
Cantimer recently announced that Robin Stracey had joined the company to lead the next phase of its growth, expanding an experienced management team that now consists of:
- Robin Stracey, President and CEO (DuPont, Dade Behring, Thermo Electron, Applied Imaging)
- Ray Stewart, Ph.D., CTO and Co-Founder (Raychem, Landec, Bay Materials)
- Jim Reed, COO, CFO, and Co–Founder (Raychem, General Electric, Bay Materials)
- James Holmes, Product Development (Raychem, Consci, Pionetics)
- Kathryn Morton, Program Management (Energy Developments, Securities Institute of Australia, Applix)
- Laurie E. Duncan, MD, Advisor, Medical Affairs (UN, NIH)